Bhattacharyya Timothy, Chang Denis, Meigs James B, Estok Daniel M, Malchau Henrik
Partners Orthopaedic Trauma Service, Yawkey 3600.
J Bone Joint Surg Am. 2007 Dec;89(12):2658-62. doi: 10.2106/JBJS.F.01538.
Management of periprosthetic femoral fractures is often complex, and few studies have documented its associated mortality.
We retrospectively identified from our trauma and surgical registries 106 patients who underwent surgery for a periprosthetic femoral fracture. We then identified a contemporaneous age and sex-matched control cohort of 309 patients who had a hip fracture (femoral neck or intertrochanteric) and 311 patients who underwent primary hip or knee replacement. Mortality at one year was identified with use of the Social Security database.
Twelve (11%) of 106 patients died within one year following surgical treatment of a periprosthetic fracture. During the same follow-up period, fifty-one (16.5%) of 309 patients died following surgery for a hip fracture and nine (2.9%) of 311 patients died following primary joint replacement. The mortality rate after a periprosthetic femoral fracture was significantly higher (p < 0.0001) compared with that for matched patients who had undergone primary joint replacement, and it was similar to the mortality rate after a hip fracture. For periprosthetic fractures, a delay of greater than two days from admission to the time of surgery was associated with an increased mortality rate at one year (p < 0.0007). Forty-nine patients underwent revision arthroplasty for the treatment of a Vancouver type-B periprosthetic fracture, and six (12%) died. In contrast, twenty-four patients with a Vancouver type-B periprosthetic fracture were treated with open reduction and internal fixation and eight (33%) died. The difference was significant (p < 0.03).
The mortality rate within one year following surgical treatment of periprosthetic femoral fractures is high and is similar to that after treatment for hip fractures. Because revision arthroplasty for the treatment of type-B periprosthetic fractures was associated with a one-year mortality rate that was significantly less than that after surgical treatment with open reduction and internal fixation, in instances when either treatment option is feasible, revision arthroplasty may be the preferred option.
人工关节周围股骨骨折的处理通常较为复杂,很少有研究记录其相关死亡率。
我们从创伤和手术登记中回顾性地识别出106例接受人工关节周围股骨骨折手术的患者。然后我们确定了一个同期年龄和性别匹配的对照队列,其中309例为髋部骨折(股骨颈或转子间骨折)患者,311例为接受初次髋或膝关节置换的患者。使用社会保障数据库确定1年时的死亡率。
106例人工关节周围骨折手术治疗的患者中有12例(11%)在术后1年内死亡。在同一随访期内,309例髋部骨折手术后有51例(16.5%)死亡,311例初次关节置换后有9例(2.9%)死亡。人工关节周围股骨骨折后的死亡率与接受初次关节置换的匹配患者相比显著更高(p < 0.0001),且与髋部骨折后的死亡率相似。对于人工关节周围骨折,从入院到手术时间延迟超过两天与1年时死亡率增加相关(p < 0.0007)。49例患者因温哥华B型人工关节周围骨折接受了关节翻修术,其中6例(12%)死亡。相比之下,24例温哥华B型人工关节周围骨折患者接受切开复位内固定治疗,8例(33%)死亡。差异有统计学意义(p < 0.03)。
人工关节周围股骨骨折手术治疗后1年内的死亡率较高,与髋部骨折治疗后的死亡率相似。由于B型人工关节周围骨折的关节翻修术相关的1年死亡率显著低于切开复位内固定手术治疗后的死亡率,在两种治疗选择均可行的情况下,关节翻修术可能是首选方案。